Just a few short days ago, an International Space Station crew returned safely to Earth after spending 196 days in space. Though the astronauts onboard spent a considerable amount of time conducting experiments, scientists closer to home have also been exploring the potential of the space environment for future innovation. Below you'll find two articles from our latest cover feature focusing on the opportunities that await the astropharmacy field.

Be sure to check out our other articles too, which delve into the responsibilities of leadership and the importance of understanding the risks and benefits of CRISPR genome editing studies. Until next time, Maryam Mahdi, Associate Editor.

 
TECHNOLOGY AND EQUIPMENT
The Astropharmacy Concept
11/17/2020 | Stephanie Sutton
How do we make medicines in space? Lynn J. Rothschild explains how biologic medicines can be made on demand.
DRUG DELIVERY
Extraterrestrial Risk
11/20/2020 | Stephanie Sutton
What biosecurity risks do exo-microorganisms pose?
ANALYTICAL SCIENCE
From Big Pharma to New Green Horizons: Lessons Learned with Ross Burn
11/16/2020 | Ross T. Burn
Ross Burn presents the story behind his career, including setting up a company on process chemistry and his views on industry 4.0.
ADVANCED MEDICINE
Informing Consent
11/16/2020 | James Strachan
Are seriously ill patients vulnerable to overestimating the benefits and underestimating the risks of gene editing studies?
 
Webinars
Exploring COVID-19 interventions with Roquette

The Medicine Maker will be hosting a webinar exploring innovations within vaccine formulations. I would like to invite you to join us and Roquette as we discuss the range of vaccines that are coming to market to tackle COVID-19. Find out more and register today! Sign me up!

Interested in AAV-based gene therapies?

Don’t miss our three-part educational webinar series with Cytiva that covers modern plasmid and AAV production for gene therapy applications. Find out more

 
White Papers
Selectively expand Tscm in serum-free, xeno-free medium

Increase the percentage of naïve T cells and stem cell memory T cells as well as the fraction of CD8+ T cells. Download the App Note to learn more

Laboratory Powder X-ray Diffraction System used for Pharmaceutical Challenges

In the pharmaceutical industry, the detection of polymorph traces is one of the most important applications for powder X-ray diffraction. Read more

Measurement of the concentration of Adeno-Associated Virus

For virus development and production, it is important to know the virus concentration at different stages of the process, to optimize the clone used as well as the production yields. Read more

 
Product Profile
Synthesising ultra-pure synthetic cannabinoids for a healthier tomorrow

JM has over 15 years’ experience in developing and commercialising a portfolio of controlled substances. Learn how our novel process for synthesising ultra-pure CBD can help you create a healthier tomorrow. Read more

 
Special Promotions
Nominate today for The Medicine Maker 2021 Power List!

Who in the drug development and manufacturing industry do you feel deserves a spot in this prestigious list? Nominate today in our three categories celebrating influential medicine makers! Find out more

The Cell + Gene Curator - a newsletter focused on the science of cell and gene therapies

Connecting you to discoveries, innovation, and business updates from the cell and gene therapy community. Learn more and subscribe

 
Must-See Events Worldwide

We work with event organizers from all around the world to help bring the pharma industry together, from large congresses to intimate meetings that fit around a table. Discover some of the events that we partner with and and stay up-to-date with the latest developments.

Find out more